STMN1 and non-small cell lung carcinoma: In another study, it was observed that non-small cell lung cancer cells respond differently to Op18/stathmin signaling when autocrine IL-10 is neutralized in vitro. Bioflavonoids are therapeutic potential candidates for lung cancer treatment.